Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC

Specialties >>

AML
Biomarker-Driven Lung Cancer
Bladder Cancer
Breast Cancer
CAR T-Cell Therapy
CLL
Colorectal Cancer
DLBCL
EGFR+ Lung Cancer
Follicular Lymphoma
Genomic Testing
GI Cancers
Gynecologic Cancers
HCC
Hematology
Immunotherapy
Leukemias
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Skin Cancers
More >>

Partners >>

Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up

Targeted Therapies in Oncology
November 2017

Clinical Articles

Guidelines Consider Use of Targeted Therapies in Colorectal Cancer
Progress for TNBC Seen Across Treatment Modalities
The Impact and Future of Entrectinib in ROS1+ NSCLC
Immunotherapy Linked to Hyperprogression of NSCLC and Other Cancers
Personalized Acuity Tool Improves Resource Utilization
EZH2 Targetability Demonstrated Across Cancer Types
Copyright © TargetedOnc 2020 Intellisphere, LLC. All Rights Reserved.